Intco Medical Technology Co., Ltd. (300677) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Intco Medical Technology Co., Ltd.

Why is Intco Medical Technology Co., Ltd. ?

The company has declared Positive results for the last 5 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 2,119.78 MM
ROCE(HY) Highest at 9.77%
RAW MATERIAL COST(Y) Fallen by -10.74% (YoY)

With ROE of 6.76%, it has a very attractive valuation with a 1.37 Price to Book Value

Over the past year, while the stock has generated a return of 123.85%, its profits have risen by 127.6% ; the PEG ratio of the company is 0.2
At the current price, the company has a high dividend yield of 0.3

Market Beating performance in long term as well as near term

Along with generating 123.85% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Intco Medical Technology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Intco Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Intco Medical Technology Co., Ltd.

123.85%

2.45

49.38%

China Shanghai Composite

15.45%

1.03

14.98%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.72%

EBIT Growth (5y)

-30.17%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.29

Tax Ratio

5.89%

Dividend Payout Ratio

6.65%

Pledged Shares

Institutional Holding

ROCE (avg)

55.32%

ROE (avg)

23.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.37

EV to EBIT

20.16

EV to EBITDA

10.25

EV to Capital Employed

1.50

EV to Sales

2.04

PEG Ratio

0.16

Dividend Yield

0.33%

ROCE (Latest)

7.46%

ROE (Latest)

6.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 2,119.78 MM

ROCE(HY)

Highest at 9.77%

RAW MATERIAL COST(Y)

Fallen by -10.74% (YoY

CASH AND EQV(HY)

Highest at CNY 44,932.97 MM

-20What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 6.46 times

INTEREST COVERAGE RATIO(Q)

Lowest at 173.9

DEBT-EQUITY RATIO (HY)

Highest at -24.58 %

INTEREST(Q)

Highest at CNY 114.65 MM

OPERATING PROFIT(Q)

Lowest at CNY 199.37 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 7.94 %

PRE-TAX PROFIT(Q)

At CNY 231.6 MM has Fallen at -29.55%

NET PROFIT(Q)

At CNY 198.71 MM has Fallen at -32.63%

Here's what is working for Intco Medical Technology Co., Ltd.

Operating Cash Flow

Highest at CNY 2,119.78 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv

Highest at CNY 44,932.97 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -10.74% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Intco Medical Technology Co., Ltd.

Interest

At CNY 114.65 MM has Grown at 20.93%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 173.9

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debtors Turnover Ratio

Lowest at 6.46 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Interest

Highest at CNY 114.65 MM

in the last five periods and Increased by 20.93% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 199.37 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 7.94 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

At CNY 231.6 MM has Fallen at -29.55%

over average net sales of the previous four periods of CNY 328.73 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 198.71 MM has Fallen at -32.63%

over average net sales of the previous four periods of CNY 294.97 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -24.58 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio